Rocket One Inc. Other Nonoperating Income (Expense)
Rocket One Inc. (RKTO) reported Other Nonoperating Income (Expense) of $27.13 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2025-03-28
- Rocket One Inc. other nonoperating income (expense) for the quarter ending 2023-12-31 was -$153.93K, a 137.52% decline year-over-year.
- Rocket One Inc. other nonoperating income (expense) for the quarter ending 2023-09-30 was $786.00.
- Rocket One Inc. other nonoperating income (expense) for the quarter ending 2022-12-31 was $410.31K, a 39164.02% increase year-over-year.
- Rocket One Inc. other nonoperating income (expense) for the quarter ending 2022-09-30 was -$592.00.
- Rocket One Inc. other nonoperating income (expense) for fiscal 2024 was $27.13K.
- Rocket One Inc. other nonoperating income (expense) for fiscal 2023 was -$153.15K, a 133.95% decline from fiscal 2022.
- Rocket One Inc. other nonoperating income (expense) for fiscal 2022 was $451.14K.
- Rocket One Inc. other nonoperating income (expense) for fiscal 2021 was -$59.58K, a 157.20% decline from fiscal 2020.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $27.13K 10-K · filed 2025-03-28 | |||||||
| 2023-12-31 | -$153.93K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$153.15K derived: sum of 2 quarters · filed 2025-03-28 | -$153.15K 10-K · filed 2025-03-28 | |||||
| 2023-09-30 | $786.00 10-Q · filed 2024-11-12 | $786.00 10-Q · filed 2024-11-12 | ||||||
| 2022-12-31 | $410.31K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $409.72K derived: sum of 2 quarters · filed 2024-03-28 | $409.45K derived: sum of 3 quarters · filed 2024-03-28 | $451.14K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$592.00 10-Q · filed 2023-11-13 | -$854.00 derived: sum of 2 quarters · filed 2023-11-13 | $40.83K 10-Q · filed 2023-11-13 | $41.88K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$262.00 10-Q · filed 2023-08-11 | $41.42K 10-Q · filed 2023-08-11 | $42.47K derived: sum of 3 quarters · filed 2023-08-11 | $13.33K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $41.69K 10-Q · filed 2023-05-15 | $42.73K derived: sum of 2 quarters · filed 2023-05-15 | $13.60K derived: sum of 3 quarters · filed 2023-05-15 | -$5.91K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$28.09K derived: sum of 2 quarters · filed 2023-03-31 | -$47.60K derived: sum of 3 quarters · filed 2023-03-31 | -$59.58K 10-K · filed 2023-03-31 | -$212.26K 10-K · filed 2022-03-30 | |||
| 2021-09-30 | -$29.14K 10-Q · filed 2022-11-10 | -$42.85K 10-Q · filed 2021-11-10 | -$48.64K derived: sum of 2 quarters · filed 2022-11-10 | -$60.63K 10-Q · filed 2022-11-10 | -$112.29K 10-Q · filed 2021-11-10 | -$14.54K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$19.51K 10-Q · filed 2022-08-12 | -$76.86K 10-Q · filed 2021-08-11 | -$31.49K 10-Q · filed 2022-08-12 | -$69.43K 10-Q · filed 2021-08-11 | $14.60K derived: sum of 3 quarters · filed 2022-08-12 | $64.50K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$11.98K 10-Q · filed 2022-05-12 | $7.43K 10-Q · filed 2021-05-13 | $34.10K derived: sum of 2 quarters · filed 2022-05-12 | $84.01K derived: sum of 3 quarters · filed 2022-05-12 | $102.30K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $46.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $96.00K derived: sum of 2 quarters · filed 2022-03-30 | $114.28K derived: sum of 3 quarters · filed 2022-03-30 | $104.16K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $49.91K 10-Q · filed 2021-11-10 | $68.19K derived: sum of 2 quarters · filed 2021-11-10 | $58.07K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $18.29K 10-Q · filed 2021-08-11 | $8.16K 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | -$10.13K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |